Broad Substrate Specificity of the Amide Synthase in S. Hygroscopicus--new 20-membered Macrolactones Derived from Geldanamycin
Overview
Authors
Affiliations
The amide synthase of the geldanamycin producer, Streptomyces hygroscopicus, shows a broader chemoselectivity than the corresponding amide synthase present in Actinosynnema pretiosum, the producer of the highly cytotoxic ansamycin antibiotics, the ansamitocins. This was demonstrated when blocked mutants of both strains incapable of biosynthesizing 3-amino-5-hydroxybenzoic acid (AHBA), the polyketide synthase starter unit of both natural products, were supplemented with 3-amino-5-hydroxymethylbenzoic acid instead. Unlike the ansamitocin producer A. pretiosum, S. hygroscopicus processed this modified starter unit not only to the expected 19-membered macrolactams but also to ring enlarged 20-membered macrolactones. The former mutaproducts revealed the sequence of transformations catalyzed by the post-PKS tailoring enzymes in geldanamycin biosynthesis. The unprecedented formation of the macrolactones together with molecular modeling studies shed light on the mode of action of the amide synthase responsible for macrocyclization. Obviously, the 3-hydroxymethyl substituent shows similar reactivity and accessibility toward C-1 of the seco-acid as the arylamino group, while phenolic hydroxyl groups lack this propensity to act as nucleophiles in the macrocyclization. The promiscuity of the amide synthase of S. hygroscopicus was further demonstrated by successful feeding of four other m-hydroxymethylbenzoic acids, leading to formation of the expected 20-membered macrocycles. Good to moderate antiproliferative activities were encountered for three of the five new geldanamycin derivatives, which matched well with a competition assay for Hsp90α.
Structure and function of the geldanamycin amide synthase from Streptomyces hygroscopicus.
Ewert W, Bartens C, Ongouta J, Holmes M, Heutling A, Kishore A Nat Commun. 2025; 16(1):2464.
PMID: 40075103 PMC: 11903869. DOI: 10.1038/s41467-025-57013-3.
Geldanamycins: Potent Hsp90 Inhibitors with Significant Potential in Cancer Therapy.
Abdullah O, Omran Z Int J Mol Sci. 2024; 25(20).
PMID: 39457075 PMC: 11509085. DOI: 10.3390/ijms252011293.
Boukouvala S, Kontomina E, Olbasalis I, Patriarcheas D, Tzimotoudis D, Arvaniti K Sci Rep. 2024; 14(1):14905.
PMID: 38942826 PMC: 11213898. DOI: 10.1038/s41598-024-65342-4.
Skrzypczak N, Pyta K, Ruszkowski P, Mikolajczak P, Kucinska M, Murias M J Enzyme Inhib Med Chem. 2021; 36(1):1898-1904.
PMID: 34344239 PMC: 8344233. DOI: 10.1080/14756366.2021.1960829.
First Ring-Expanded Maytansin Lactone Accessed by a New Mutasynthetic Variant.
Wesemann F, Heutling A, Wienecke P, Kirschning A Chembiochem. 2020; 21(20):2927-2930.
PMID: 32484951 PMC: 7689855. DOI: 10.1002/cbic.202000336.